Spinraza

Indicated For

Spinal Muscular Atrophy, SMA

About This Medication

# Biogen Support Services: Spinraza Patient Guide: How to Get Spinraza (nusinersen) at Low or No Cost Spinraza (nusinersen) is a prescription medication used to treat spinal muscular atrophy (SMA) in both pediatric and adult patients, administered via spinal injection by a healthcare provider.[6] The **Biogen Support Services: Spinraza** program from Biogen helps eligible underinsured or uninsured patients access Spinraza at low or no cost through needs-based financial assistance, while a separate copay program supports commercially insured patients (excluding government insurance like Medicare or Medicaid).[3][5] ## About Spinraza and SMA **Spinraza** is an FDA-approved treatment for SMA, a rare genetic disease that causes muscle weakness and loss of motor function due to a deficiency in survival motor neuron (SMN) protein.[6] It works by increasing SMN protein production to help improve muscle function and strength. Treatments are given every four months after loading doses, typically in a clinic or hospital via lumbar puncture.[2][9] Discuss with your healthcare provider (HCP) if Spinraza is right for you, including potential benefits, risks, and monitoring needs.[2] ## Who Qualifies for the Program? This program targets **underinsured or uninsured** U.S. residents (including Puerto Rico) prescribed Spinraza for an FDA-approved indication.[3] Eligibility is **needs-based**, meaning Biogen assesses financial situations individually rather than using fixed income thresholds like Federal Poverty Level (FPL) percentages.[3] Patients must be enrolled via a Start Form submitted by their HCP, and support includes free medication for eligible patients.[1][3][4] **Separate Copay Program:** Commercially insured patients (not government insurance) can get copay assistance for Spinraza and treatment procedures, regardless of income, with no annual maximum.[5] Enroll separately. ## Income Eligibility Breakdown Specific income limits are not publicly detailed; eligibility is determined case-by-case based on financial need.[3] Biogen's team reviews proof of income to approve assistance. | Household Size | Income Threshold | Notes | |---------------|------------------|-------| | Individual | Not specified | Needs-based assessment required[3] | | Couple | Not specified | Needs-based assessment required[3] | | Family of 3 | Not specified | Needs-based assessment required[3] | | Family of 4 | Not specified | Needs-based assessment required[3] | | FPL % | Not applicable | Case-by-case review[3] | Contact Biogen at (844) 477-4672 for a personalized eligibility check.[3][9] ## Insurance Requirements - **Primary Program:** For **uninsured or underinsured** patients. No coverage required, but provide insurance/pharmacy benefit cards if applicable.[3][4] - **Copay Program:** For **commercial insurance only** (excludes Medicare, Medicaid, etc.). Insurance pays first, then copay help applies.[5] - Biogen's SMA360° team assists with benefits investigation, prior authorizations, and appeals.[9][10] ## Step-by-Step Application Process 1. **Consult Your HCP:** Schedule an appointment to discuss Spinraza. If appropriate, your HCP prescribes it and starts enrollment.[2][10] 2. **Complete the Start Form:** Download (English/Spanish) or e-sign the form.[1][4] Patient consents and provides info; HCP completes prescription section.[4] 3. **Gather Documents:** - **Enrollment Form** (Start Form) - **Proof of residency** (e.g., utility bill) - **Proof of income** (e.g., tax returns, pay stubs) - Insurance/pharmacy cards (both sides, if available)[1][3][4] 4. **Submit to Biogen:** HCP faxes to 1-888-538-9781 or emails StartForm@biogen.com (unattended inbox for forms only).[1][3][4] 5. **Biogen Contact:** A **Family Access Manager (FAM)** or **Lead Case Manager (LCM)** calls to guide you, confirm eligibility, and handle logistics (Mon-Fri, 8:30 AM-8 PM ET).[1][8][9] 6. **Approval and Next Steps:** Biogen coordinates insurance (if any), specialty pharmacy, or direct buy. Medication ships to you or your provider.[3] Call (844) 477-4672 for help anytime.[3][6][9] ## Timeline and Delivery Processing time varies based on insurance and completeness of forms—incomplete submissions delay access.[4][9] After submission: - FAM/LCM contacts you soon after.[1][8] - Insurance benefits investigation and prior auth (if needed): Days to weeks.[9] - Once approved, treatment center schedules your first dose; medication is **shipped to the patient** or provider.[3][9] Expect ongoing support from your SMA360° team for refills and reauthorizations.[5][8] ## Reauthorization **Reauthorization is required** periodically, as SMA treatment is ongoing. Your HCP submits updates, and Biogen handles renewals with your FAM/LCM.[3] ## Alternatives if Denied - **Appeal:** Work with your FAM for insurance appeals or program reconsideration.[9] - **Copay Program:** Switch if commercially insured.[5] - **Other Resources:** Contact Cure SMA or state programs; no biosimilars available.[6] - **Clinical Trials:** Ask your HCP about SMA studies.[10] ## Disclaimer This guide is for informational purposes based on available program details as of 2026 and is not medical or financial advice. Eligibility, benefits, and terms can change; confirm with Biogen at (844) 477-4672 or your HCP. Biogen services are for U.S. residents prescribed Spinraza only.[3][8] Always follow your doctor's guidance.

Program information last verified: March 30, 2026